Lifeward (LFWD) Expected to Announce Quarterly Earnings on Thursday

Lifeward (NASDAQ:LFWD) is anticipated to announce its Q2 2025 earnings results before the market opens on Thursday, August 14th. Analysts expect the company to announce earnings of ($0.25) per share and revenue of $6.62 million for the quarter. Lifeward has set its FY 2025 guidance at EPS.

Lifeward (NASDAQ:LFWD) last issued its earnings results on Thursday, May 15th. The company reported ($0.46) EPS for the quarter, missing the consensus estimate of ($0.33) by ($0.13). Lifeward had a negative return on equity of 101.96% and a negative net margin of 108.21%. The business had revenue of $5.03 million for the quarter, compared to the consensus estimate of $5.84 million. On average, analysts expect Lifeward to post $-2 EPS for the current fiscal year and $0 EPS for the next fiscal year.

Lifeward Trading Up 2.5%

Shares of NASDAQ LFWD opened at $0.69 on Tuesday. Lifeward has a 12 month low of $0.50 and a 12 month high of $4.29. The stock has a 50 day moving average of $0.85 and a 200-day moving average of $1.29. The company has a market capitalization of $7.56 million, a P/E ratio of -0.23 and a beta of 0.09.

About Lifeward

ReWalk Robotics Ltd., a medical device company, designs, develops, and commercializes technologies that enable mobility and wellness in rehabilitation and daily life for individuals with physical and neurological conditions in the United States, Europe, the Asia-Pacific, and internationally. It offers ReWalk personal exoskeleton and rehabilitation exoskeleton devices; ReStore, a soft exo-suit intended for use in the rehabilitation of individuals with lower limb disability due to stroke; AlterG Anti-Gravity System for use in physical and neurological rehabilitation and athletic training; MyoCycle devices; and ReBoot, a personal soft exo-suit for home and community use by individuals post-stroke.